Skip Nav Destination
Issues
1 December 2013
-
Cover Image
Cover Image
The cover shows a human U251-MG glioblastoma cell transfected with 100 nM of non-target siRNA. Phalloidin (green) and DAPI (blue) staining shows organized F-actin and cell morphology. For details, see the article by Zheng and colleagues on page 6484 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR New Strategies
Molecular Pathways
CCR Focus
Human Cancer Biology
Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genome-wide Association Study
Jiping Wang; Luis G. Carvajal-Carmona; Jen-Hwa Chu; Ann G. Zauber; APC Trial Collaborators; Michikai Kubo; Koichi Matsuda; Malcolm Dunlop; Richard S. Houlston; Oliver Sieber; Lara Lipton; Peter Gibbs; Nicholas G. Martin; Grant W. Montgomery; Joanne Young; Paul N. Baird; Mark J. Ratain; Yusuke Nakamura; Scott T. Weiss; Ian Tomlinson; Monica M. Bertagnolli
Contrasting Expression Patterns of Histone mRNA and microRNA 760 in Patients with Gastric Cancer
Takeshi Iwaya; Takeo Fukagawa; Yutaka Suzuki; Yusuke Takahashi; Genta Sawada; Masahisa Ishibashi; Junji Kurashige; Tomoya Sudo; Fumiaki Tanaka; Kohei Shibata; Fumitaka Endo; Hirokatsu Katagiri; Kaoru Ishida; Kohei Kume; Satoshi Nishizuka; Hisae Iinuma; Go Wakabayashi; Masaki Mori; Mitsuru Sasako; Koshi Mimori
Cancer Therapy: Preclinical
Author Choice
A Genetically Engineered Oncolytic Adenovirus Decoys and Lethally Traps Quiescent Cancer Stem–like Cells in S/G2/M Phases
Shuya Yano; Hiroshi Tazawa; Yuuri Hashimoto; Yasuhiro Shirakawa; Shinji Kuroda; Masahiko Nishizaki; Hiroyuki Kishimoto; Futoshi Uno; Takeshi Nagasaka; Yasuo Urata; Shunsuke Kagawa; Robert M. Hoffman; Toshiyoshi Fujiwara
The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
Marion A. Salvador; Julien Wicinski; Olivier Cabaud; Yves Toiron; Pascal Finetti; Emmanuelle Josselin; Hélène Lelièvre; Laurence Kraus-Berthier; Stéphane Depil; François Bertucci; Yves Collette; Daniel Birnbaum; Emmanuelle Charafe-Jauffret; Christophe Ginestier
Targeting Src and Tubulin in Mucinous Ovarian Carcinoma
Tao Liu; Wei Hu; Heather J. Dalton; Hyun Jin Choi; Jie Huang; Yu Kang; Sunila Pradeep; Takahito Miyake; Jian H. Song; Yunfei Wen; Chunhua Lu; Chad V. Pecot; Justin Bottsford-Miller; Behrouz Zand; Nicholas B. Jennings; Cristina Ivan; Gary E. Gallick; Keith A. Baggerly; David G. Hangauer; Robert L. Coleman; Michael Frumovitz; Anil K. Sood
Imaging, Diagnosis, Prognosis
Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
Joo Mi Yi; Angela A. Guzzetta; Vasudev J. Bailey; Stephanie R. Downing; Leander Van Neste; Katherine B. Chiappinelli; Brian P. Keeley; Alejandro Stark; Alexander Herrera; Christopher Wolfgang; Emmanouil P. Pappou; Christine A. Iacobuzio-Donahue; Michael G. Goggins; James G. Herman; Tza-Huei Wang; Stephen B. Baylin; Nita Ahuja
EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma
Carmen Behrens; Luisa M. Solis; Heather Lin; Ping Yuan; Ximing Tang; Humam Kadara; Erick Riquelme; Hector Galindo; Cesar A. Moran; Neda Kalhor; Stephen G. Swisher; George R. Simon; David J. Stewart; J. Jack Lee; Ignacio I. Wistuba
Cancer Therapy: Clinical
A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112)
Patrick A. Thompson; Rachid Drissi; Jodi A. Muscal; Eshini Panditharatna; Maryam Fouladi; Ashish M. Ingle; Charlotte H. Ahern; Joel M. Reid; Tong Lin; Brenda J. Weigel; Susan M. Blaney
Author Choice
Photodynamic Therapy with 3-(1′-Hexyloxyethyl) Pyropheophorbide a for Cancer of the Oral Cavity
Nestor Rigual; Gal Shafirstein; Michele T. Cooper; Heinz Baumann; David A. Bellnier; Ulas Sunar; Erin C. Tracy; Daniel J. Rohrbach; Gregory Wilding; Wei Tan; Maureen Sullivan; Mihai Merzianu; Barbara W. Henderson
A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
Andrew X. Zhu; Richard S. Finn; Mary Mulcahy; Jayne Gurtler; Weijing Sun; Jonathan D. Schwartz; Rita P. Dalal; Adarsh Joshi; Rebecca R. Hozak; Yihuan Xu; Marek Ancukiewicz; Rakesh K. Jain; Francis W. Nugent; Dan G. Duda; Keith Stuart
Predictive Biomarkers and Personalized Medicine
A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab
Oliver W. Press; Joseph M. Unger; Lisa M. Rimsza; Jonathan W. Friedberg; Michael LeBlanc; Myron S. Czuczman; Mark Kaminski; Rita M. Braziel; Catherine Spier; Ajay K. Gopal; David G. Maloney; Bruce D. Cheson; Shaker R. Dakhil; Thomas P. Miller; Richard I. Fisher
Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers
Ranee Mehra; Fang Zhu; Dong-Hua Yang; Kathy Q. Cai; JoEllen Weaver; Mahendra K. Singh; Anna S. Nikonova; Erica A. Golemis; Douglas B. Flieder; Harry S. Cooper; Miriam Lango; John A. Ridge; Barbara Burtness
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds